(Press-News.org) A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
The findings, based on AD mouse models and published online in the Journal of Alzheimer's Disease, support continued development of cysteine protease inhibitors as a new drug target class for AD. "No other therapeutic program is investigating cysteine protease inhibitors for treating AD," said collaborator Vivian Hook, PhD, professor in the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and in the UC San Diego School of Medicine.
Current AD drugs treat some symptoms of the devastating neurological disorder, but none actually slow its progress, prevent or cure it. No new AD drug has been approved in more than a decade.
The researchers focused on cathepsin B production of N-truncated pGlu-Aβ, a peptide or short chain of amino acids, and the blockade of cathepsin B by E64d, a compound shown to inhibit cysteine proteases, a type of enzyme. AD is characterized by accumulation of a variety of Aβ peptides as oligomers and amyloid plaques in the brain, factors involved in neuronal loss and memory deficits over time. These neurotoxic Aβ peptides are created when enzymes cleave a large protein called amyloid precursor protein (APP) into smaller Aβ peptides of varying toxicity. N-truncated pGlu-Aβ has been shown to be among the most neurotoxic of multiple forms of Aβ peptides.
Much AD research has focused on the APP-cutting enzyme BACE1 β-secretase, but its role in producing pGlu-Aβ was unknown. Cathepsin B is an alternative β-secretase which cleaves the wild-type β-secretase site of APP, which is expressed in the major sporadic and many familial forms of AD. Hook and colleagues looked at what happened after gene knockout of BACE1 or cathepsin B. They found that cathepsin B, but not BACE1, produced the highly toxic pGlu-Aβ.
Perhaps most interestingly, the scientists found that E64d, an enzyme inhibitor of cathepsin B, reduced production of pGlu-Aβ and other AD-associated Aβ peptides. Key was the finding that E64d and cathepsin B gene knock out resulted in improved memory deficits in a mouse model of AD.
"This is an exciting finding," said Hook. "It addresses a new target – cathepsin B – and an effective, safe small molecule, E64d, to reduce the pGlu-Aβ that initiates development of the disease's neurotoxicity. No other work in the field has addressed protease inhibition for reducing pGlu-Aβ of AD."
Hook noted that E64d has already been shown to be safe in clinical trials of patients with muscular dystrophy and would, therefore, likely prove safe for treating AD as well. She hopes to launch Phase 1 human clinical trials in the near future with a modified version of the drug candidate.
INFORMATION:
Co-authors include Gregory Hook, American Life Science Pharmaceuticals, Inc.; Jin Yu and Mark Kindy, Medical University of South Carolina; and Thomas Toneff, UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences.
Funding for this research came, in part, from the National Institutes of Health (grants R44AG032784, R01ES016774-02 and R21AG0428), a Veteran's Affairs Merit Review grant, and an Alzheimer's Association award.
Disclosure: Vivian Hook is chair of American Life Science Pharmaceuticals' scientific advisory board and holds equity in the company.
New therapeutic target discovered for Alzheimer's disease
Drug candidate blocks production of disease-causing neurotoxins in mouse models
2014-03-18
ELSE PRESS RELEASES FROM THIS DATE:
Chronic sleep disturbance could trigger onset of Alzheimer's
2014-03-18
People who experience chronic sleep disturbance—either through their work, insomnia or other reasons—could face an earlier onset of dementia and Alzheimer's, according to a new pre-clinical study by researchers at Temple University.
"The big biological question that we tried to address in this study is whether sleep disturbance is a risk factor to develop Alzheimer's or is it something that manifests with the disease," said Domenico Praticò, professor of pharmacology and microbiology/immunology in Temple's School of Medicine, who led the study.
Initially, the researchers ...
Parents matter more than they think in how their children eat
2014-03-18
AURORA, Colo. (March 17, 2014) - Helping children learn to eat well can be a challenge. Some children happily eat whatever is put in front of them while others seem to eat like birds and exist more on air than food. A new study by a researcher at the University of Colorado School of Medicine shows that parents influence how much children eat more than they may think.
In this collaborative study between the CU School of Medicine, Baylor College of Medicine and University of Alabama Birmingham, researchers observed normal, everyday mealtimes in the homes of 145 parents ...
An end to animal testing for drug discovery?
2014-03-18
DALLAS, March 18, 2014 — As some countries and companies roll out new rules to limit animal testing in pharmaceutical products designed for people, scientists are stepping in with a new way to test therapeutic drug candidates and determine drug safety and drug interactions — without using animals. The development of "chemosynthetic livers," which could dramatically alter how drugs are made, was presented at the 247th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society.
The meeting features more than 10,000 presentations ...
Form of epilepsy in sea lions similar to that in humans, Stanford researchers find
2014-03-18
STANFORD, Calif. — California sea lions exposed to a toxin in algae develop a form of epilepsy that is similar to one in humans, according to a new study led by Stanford University School of Medicine researchers.
Every year, hundreds of sea lions wash up along the California coast, suffering seizures caused by exposure to domoic acid, a neurotoxin that can produce memory loss, tremors, convulsions and death. Domoic acid is produced by algae blooms that have been proliferating along the coast in recent years, accumulating in anchovies and other small fish that the sea ...
New view of supernova death throes
2014-03-18
WASHINGTON D.C., March 18, 2014 -- A powerful, new three-dimensional model provides fresh insight into the turbulent death throes of supernovas, whose final explosions outshine entire galaxies and populate the universe with elements that make life on Earth possible.
The model is the first to represent the start of a supernova collapse in three dimensions, said its developer, W. David Arnett, Regents Professor of Astrophysics at the University of Arizona, who developed the model with Casey Meakin and Nathan Smith at Arizona and Maxime Viallet of the Max-Planck Institut ...
Nineteen new speedy praying mantis species discovered that hide and play dead to avoid capture
2014-03-18
A scientist has discovered 19 new species of praying mantis from Central and South America. The new species of bark mantises were discovered in tropical forests and also found among existing museum collections. Dr. Gavin Svenson, curator of invertebrate zoology at The Cleveland Museum of Natural History, described the new species and published a revision of the genus Liturgusa in the open access journal ZooKeys.
Svenson collected the insects from eight countries in Central and South America, as well as gathered hundreds of specimens from 25 international museums in ...
Child ADHD stimulant medication use leads to BMI rebound in late adolescence
2014-03-18
A new study from researchers at Johns Hopkins Bloomberg School of Public Health found that children treated with stimulants for attention deficit hyperactivity disorder (ADHD) experienced slower body mass index (BMI) growth than their undiagnosed or untreated peers, followed by a rapid rebound of BMI that exceeded that of children with no history of ADHD or stimulant use and that could continue to obesity.
The study, thought to be the most comprehensive analysis of ADHD and stimulant use in children to date, found that the earlier the medication began, and the longer ...
Nanopores control the inner ear's ability to select sounds
2014-03-18
Even in a crowded room full of background noise, the human ear is remarkably adept at tuning in to a single voice — a feat that has proved remarkably difficult for computers to match. A new analysis of the underlying mechanisms, conducted by researchers at MIT, has provided insights that could ultimately lead to better machine hearing, and perhaps to better hearing aids as well.
Our ears' selectivity, it turns out, arises from evolution's precise tuning of a tiny membrane, inside the inner ear, called the tectorial membrane. The viscosity of this membrane — its firmness, ...
Variations in eye structure and function may reveal features of early-stage Alzheimer's disease
2014-03-18
LOS ANGELES (March 18, 2014) – Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.
Alzheimer's disease is the leading cause of dementia, which is characterized by loss of memory and a progressive decline in cognitive function. To date, more than 26 million people ...
Children exposed to methamphetamine before birth have increased cognitive problems
2014-03-18
LOS ANGELES – (March 18, 2014) – In the only long-term, National Institutes of Health-funded study of prenatal methamphetamine exposure and child outcome, researchers found youngsters exposed to the potent illegal drug before birth had increased cognitive problems at age 7.5 years, highlighting the need for early intervention to improve academic outcomes and reduce the potential for negative behaviors, according to the study published online by The Journal of Pediatrics.
The researchers studied 151 children exposed to methamphetamine before birth and 147 who were not ...
LAST 30 PRESS RELEASES:
Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training
Day-long conference addresses difficult to diagnose lung disease
First-ever cardiogenic shock academy features simulation lab
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
[Press-News.org] New therapeutic target discovered for Alzheimer's diseaseDrug candidate blocks production of disease-causing neurotoxins in mouse models